ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $466,000 | -19.0% | 39,629 | -5.8% | 0.00% | -100.0% |
| Q1 2019 | $575,000 | +49.7% | 42,081 | +12.0% | 0.00% | – |
| Q4 2018 | $384,000 | +4.1% | 37,575 | +69.9% | 0.00% | – |
| Q3 2018 | $369,000 | +5.7% | 22,110 | 0.0% | 0.00% | – |
| Q2 2018 | $349,000 | +24.2% | 22,110 | 0.0% | 0.00% | – |
| Q1 2018 | $281,000 | +11.1% | 22,110 | 0.0% | 0.00% | – |
| Q4 2017 | $253,000 | -6.6% | 22,110 | 0.0% | 0.00% | – |
| Q3 2017 | $271,000 | +8.4% | 22,110 | +6.2% | 0.00% | – |
| Q2 2017 | $250,000 | -43.3% | 20,810 | -1.4% | 0.00% | – |
| Q1 2017 | $441,000 | -38.0% | 21,100 | -38.2% | 0.00% | -100.0% |
| Q4 2016 | $711,000 | -68.9% | 34,161 | -51.7% | 0.00% | -50.0% |
| Q3 2016 | $2,288,000 | +52.3% | 70,698 | +17.5% | 0.00% | 0.0% |
| Q2 2016 | $1,502,000 | +205.3% | 60,167 | +199.2% | 0.00% | +100.0% |
| Q1 2016 | $492,000 | -23.6% | 20,112 | +5.5% | 0.00% | 0.0% |
| Q4 2015 | $644,000 | +3.0% | 19,070 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $625,000 | -47.7% | 19,070 | -15.5% | 0.00% | 0.0% |
| Q2 2015 | $1,196,000 | – | 22,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |